JAVMA news
Old, new deputy CEO see AVMA moving profession forward
What kept Dr. Elizabeth A. Curry-Galvin on the staff of the AVMA for two decades?
JAVMA news
Q&A with Dr. Elizabeth A. Curry-Galvin
Dr. Elizabeth A. Curry-Galvin, outgoing deputy chief executive officer of the AVMA, answers questions from JAVMA News.
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
AVMA advocates against prescription mandate bill
In April, AVMA Board of Directors chair Dr. John de Jong testified before a House subcommittee about the Fairness to Pet Owners Act (HR 3174/S 1200),
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…
AVMA news
Advances in animal genome editing continue apace
The Food and Drug Administration (FDA) recently green lit for human consumption five genetically modified pigs at Washington State University.…